Search - tctmd.com

Displaying 121 - 140 of 195

Sort: Relevancy | Date

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

May 19, 2015

News Daily News

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

May 08, 2015

News Daily News

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

May 08, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

May 08, 2015

5-Year Outcomes of PCI vs CABG in Patients  With Diabetes Mellitus

Presentation

5-Year Outcomes of PCI vs CABG in Patients  With Diabetes Mellitus

Presenter: Akira Marui

February 08, 2015

News Daily News

CREDO-Kyoto: Diabetic Patients With 3-Vessel or Left Main Disease Fare Better With CABG

February 08, 2015

News Daily News

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

November 17, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

November 17, 2014

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

November 17, 2014

News Daily News

急性高血糖使AMI后预后恶化

October 24, 2014

News Daily News

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

October 24, 2014

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

October 17, 2014

News Daily News

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

October 10, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.